Neuropeptide Y-like immunoreactivity in schizophrenia
- 1 October 1990
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 3 (5-6) , 287-294
- https://doi.org/10.1016/0920-9964(90)90012-v
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Effects of centrally administered neuropeptide Y (NPY) and NPY13?36 on the brain monoaminergic systems of the ratJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1990
- Neuropeptide Y reduces ovarian blood flow in the rabbitPeptides, 1990
- Age at Puberty and Mental IllnessThe British Journal of Psychiatry, 1989
- Neuropeptide Y increases the inhibitory effects of clonidine on potassium evoked3H-noradrenaline but not3H-5-hydroxytryptamine release from synaptosomes of the hypothalamus and the frontoparietal cortex of the male Sprague-Dawley ratJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- Serotonin innervation of neuropeptide Y-containing neurons in the rat arcuate nucleusNeuroscience Letters, 1988
- Structural brain pathology in schizophrenia revisited *1Prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acidNeuropsychopharmacology, 1987
- Autonomic nervous system activity in autistic, schizophrenic, and normal men: Effects of stimulus significance.Journal of Abnormal Psychology, 1987
- Neuropeptide Y immunoreactivity in human cerebrospinal fluidPeptides, 1986
- New paradigm: sympathetic transmission by multiple messengers and lateral interaction between monoquantal release sites?Trends in Neurosciences, 1986
- Neuropeptide Y distribution in human brainNature, 1983